cyber_indian said:
Although the technology is still in its infancy, it has been used with some success.
Hmmm, “
some” being the operative word here.
As far as I am aware gene therapy has been a tremendous failure for over a decade now and has in no way lived up to its hype. There have been only a tiny handful of successful cases and at least one death (that I know of) as a result of attempted gene therapy.
The reason for its failure to live up to all the hype is, of course, that there are very few efficient and specific delivery mechanisms. Modified viruses have been the delivery vector of choice, but aside from viruses that infect the respiratory tract epithelial/mucosal cells there are little or no good candidates. So the only two types of genetic disease that are treatable with current technology are cystic fibrosis and bone marrow diseases (because haematopoietic stem cells are relatively easy to extract, culture, transfect and re-insert into the marrow).
So this is what prompted me to question you because I am wondering how you are proposing that an ingested tablet will deliver DNA to specific cells somewhere in the body.
And then you mention surgery. I would suggest that most surgeries have nothing to do with heritable genetic disease. How do you propose that gene therapy is going to greatly impact surgery?
And then you mention AIDS. HIV is an environmentally acquired infection, nothing to do with heritable genetic disease. How do you propose that gene therapy is going to greatly impact HIV treatments or other infections?
(You may potentially be thinking of RNAi-based treatments when it comes to things like HIV and other pathologies, but potential RNAi treatments suffer from exactly the same delivery problems as gene therapy.)<P>